XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated (Deficit) [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Total
Beginning balance at Dec. 31, 2015 $ 761 $ 5,886,971 $ (6,306,297) $ (100,000) $ (148,651) $ (667,216)
Beginning balance, shares at Dec. 31, 2015 7,612,838     (1,000,000)    
Atrinsic shares converted $ 1 $ 3 63,381 63,385
Atrinsic shares converted, shares 297,468 25,867          
Protagenic shares converted $ 6 $ (761) (99,245) $ 100,000
Protagenic shares converted, shares 6,612,838 (7,612,838)     1,000,000    
Private offerings, net of expenses $ 4 4,761,793 4,761,797
Private offerings, net of expenses, shares 4,108,460            
Foreign currency translation gain (loss) (32,984) (32,984)
Stock compensation - stock options 546,134 546,134
Conversion of series B Preferred Stock $ (10) $ 1,015 (1,005)
Conversion of series B Preferred Stock, shares (10,146,000) 10,146,000          
Conversion of Bridge loan $ 6 75,259 75,265
Conversion of Bridge loan, shares 60,211          
Stock options converted to common $ 2 6,498 6,500
Stock options converted to common, shares 25,000          
Net Loss (2,275,826) (2,275,826)
Ending balance at Dec. 31, 2016 $ 1 $ 1,026 11,239,786 (8,582,123) (181,635) 2,477,055
Ending balance, shares at Dec. 31, 2016 872,766 10,257,078          
Foreign currency translation gain (loss) 15,256 15,256
Stock compensation - stock options 888,281 888,281
Unrealized gain (loss) on marketable securities (1,426) (1,426)
Adjustment to common stock
Adjustment to common stock, shares 4,341          
Modification of warrants 99,782 99,782
Net Loss (2,259,636) (2,259,636)
Ending balance at Dec. 31, 2017 $ 1 $ 1,026 $ 12,227,849 $ (10,841,759) $ (167,805) $ 1,219,312
Ending balance, shares at Dec. 31, 2017 872,766 10,261,419